184 related articles for article (PubMed ID: 15277228)
1. Expression of the type-1 repeats of thrombospondin-1 inhibits tumor growth through activation of transforming growth factor-beta.
Yee KO; Streit M; Hawighorst T; Detmar M; Lawler J
Am J Pathol; 2004 Aug; 165(2):541-52. PubMed ID: 15277228
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-beta-dependent and -independent mechanisms.
Miao WM; Seng WL; Duquette M; Lawler P; Laus C; Lawler J
Cancer Res; 2001 Nov; 61(21):7830-9. PubMed ID: 11691800
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats.
Iruela-Arispe ML; Lombardo M; Krutzsch HC; Lawler J; Roberts DD
Circulation; 1999 Sep; 100(13):1423-31. PubMed ID: 10500044
[TBL] [Abstract][Full Text] [Related]
4. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta.
Ribeiro SM; Poczatek M; Schultz-Cherry S; Villain M; Murphy-Ullrich JE
J Biol Chem; 1999 May; 274(19):13586-93. PubMed ID: 10224129
[TBL] [Abstract][Full Text] [Related]
5. Topical Application of TGF-β-Activating Peptide, KRFK, Prevents Inflammatory Manifestations in the TSP-1-Deficient Mouse Model of Chronic Ocular Inflammation.
Soriano-Romaní L; Contreras-Ruiz L; López-García A; Diebold Y; Masli S
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577496
[TBL] [Abstract][Full Text] [Related]
6. Halofuginone inhibits tumor growth in the polyoma middle T antigen mouse via a thrombospondin-1 independent mechanism.
Yee KO; Connolly CM; Pines M; Lawler J
Cancer Biol Ther; 2006 Feb; 5(2):218-24. PubMed ID: 16418571
[TBL] [Abstract][Full Text] [Related]
7. Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor β signal activation and liver regeneration after hepatectomy in an experimental model.
Kuroki H; Hayashi H; Nakagawa S; Sakamoto K; Higashi T; Nitta H; Hashimoto D; Chikamoto A; Beppu T; Baba H
Br J Surg; 2015 Jun; 102(7):813-25. PubMed ID: 25866938
[TBL] [Abstract][Full Text] [Related]
8. The tryptophan-rich motifs of the thrombospondin type 1 repeats bind VLAL motifs in the latent transforming growth factor-beta complex.
Young GD; Murphy-Ullrich JE
J Biol Chem; 2004 Nov; 279(46):47633-42. PubMed ID: 15342643
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis.
Streit M; Riccardi L; Velasco P; Brown LF; Hawighorst T; Bornstein P; Detmar M
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14888-93. PubMed ID: 10611308
[TBL] [Abstract][Full Text] [Related]
10. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth.
Lawler J
J Cell Mol Med; 2002; 6(1):1-12. PubMed ID: 12003665
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas.
Streit M; Velasco P; Brown LF; Skobe M; Richard L; Riccardi L; Lawler J; Detmar M
Am J Pathol; 1999 Aug; 155(2):441-52. PubMed ID: 10433937
[TBL] [Abstract][Full Text] [Related]
12. An N-terminal 80 kDa recombinant fragment of human thrombospondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo.
Noh YH; Matsuda K; Hong YK; Kunstfeld R; Riccardi L; Koch M; Oura H; Dadras SS; Streit M; Detmar M
J Invest Dermatol; 2003 Dec; 121(6):1536-43. PubMed ID: 14675207
[TBL] [Abstract][Full Text] [Related]
13. c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma.
Kiyono K; Suzuki HI; Morishita Y; Komuro A; Iwata C; Yashiro M; Hirakawa K; Kano MR; Miyazono K
Cancer Sci; 2009 Oct; 100(10):1809-16. PubMed ID: 19594546
[TBL] [Abstract][Full Text] [Related]
14. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta.
Schultz-Cherry S; Lawler J; Murphy-Ullrich JE
J Biol Chem; 1994 Oct; 269(43):26783-8. PubMed ID: 7929414
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of thrombospondin-1.
Guo NH; Krutzsch HC; Inman JK; Shannon CS; Roberts DD
J Pept Res; 1997 Sep; 50(3):210-21. PubMed ID: 9309585
[TBL] [Abstract][Full Text] [Related]
16. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
[TBL] [Abstract][Full Text] [Related]
17. Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptide.
Aghi M; Rabkin SD; Martuza RL
Cancer Res; 2007 Jan; 67(2):440-4. PubMed ID: 17234749
[TBL] [Abstract][Full Text] [Related]
18. Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis.
García-Quiroz J; Rivas-Suárez M; García-Becerra R; Barrera D; Martínez-Reza I; Ordaz-Rosado D; Santos-Martinez N; Villanueva O; Santos-Cuevas CL; Avila E; Gamboa-Domínguez A; Halhali A; Larrea F; Díaz L
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():215-22. PubMed ID: 24120914
[TBL] [Abstract][Full Text] [Related]
19. Thrombospondin 1 acts as a strong promoter of transforming growth factor beta effects via two distinct mechanisms in hepatic stellate cells.
Breitkopf K; Sawitza I; Westhoff JH; Wickert L; Dooley S; Gressner AM
Gut; 2005 May; 54(5):673-81. PubMed ID: 15831915
[TBL] [Abstract][Full Text] [Related]
20. A peptide antagonist of thrombospondin-1 promotes abdominal aortic aneurysm progression in the angiotensin II-infused apolipoprotein-E-deficient mouse.
Krishna SM; Seto SW; Jose RJ; Biros E; Moran CS; Wang Y; Clancy P; Golledge J
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):389-98. PubMed ID: 25524772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
